Background Immunohistochemistry (IHC) has played an essential role in the diagnosis of hematolymphoid neoplasms. However, IHC interpretations can be challenging in daily practice, and exponentially expanding volumes of IHC data are making the task increasingly difficult. We therefore developed a machine-learning expert-supporting system for diagnosing lymphoid neoplasms.
Methods A probabilistic decision-tree algorithm based on the Bayesian theorem was used to develop mobile application software for iOS and Android platforms. We tested the software with real data from 602 training and 392 validation cases of lymphoid neoplasms and compared the precision hit rates between the training and validation datasets.
Results IHC expression data for 150 lymphoid neoplasms and 584 antibodies was gathered. The precision hit rates of 94.7% in the training data and 95.7% in the validation data for lymphomas were not statistically significant. Results in most B-cell lymphomas were excellent, and generally equivalent performance was seen in T-cell lymphomas. The primary reasons for lack of precision were atypical IHC profiles for certain cases (e.g., CD15-negative Hodgkin lymphoma), a lack of disease-specific markers, and overlapping IHC profiles of similar diseases.
Conclusions Application of the machine-learning algorithm to diagnosis precision produced acceptable hit rates in training and validation datasets. Because of the lack of origin- or disease- specific markers in differential diagnosis, contextual information such as clinical and histological features should be taken into account to make proper use of this system in the pathologic decision-making process.
Citations
Citations to this article as recorded by
Revolutionizing Pathology with Artificial Intelligence: Innovations in Immunohistochemistry Diana Gina Poalelungi, Anca Iulia Neagu, Ana Fulga, Marius Neagu, Dana Tutunaru, Aurel Nechita, Iuliu Fulga Journal of Personalized Medicine.2024; 14(7): 693. CrossRef
Enhanced Immunohistochemistry Interpretation with a Machine Learning-Based Expert System Anca Iulia Neagu, Diana Gina Poalelungi, Ana Fulga, Marius Neagu, Iuliu Fulga, Aurel Nechita Diagnostics.2024; 14(17): 1853. CrossRef
Optimization of diagnosis and treatment of hematological diseases via artificial intelligence Shi-Xuan Wang, Zou-Fang Huang, Jing Li, Yin Wu, Jun Du, Ting Li Frontiers in Medicine.2024;[Epub] CrossRef
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion Emmilia Hodak, Larisa Geskin, Emmanuella Guenova, Pablo L. Ortiz-Romero, Rein Willemze, Jie Zheng, Richard Cowan, Francine Foss, Cristina Mangas, Christiane Querfeld American Journal of Clinical Dermatology.2023; 24(1): 5. CrossRef
Validation of a Machine Learning Expert Supporting System, ImmunoGenius, Using Immunohistochemistry Results of 3000 Patients with Lymphoid Neoplasms Jamshid Abdul-Ghafar, Kyung Jin Seo, Hye-Ra Jung, Gyeongsin Park, Seung-Sook Lee, Yosep Chong Diagnostics.2023; 13(7): 1308. CrossRef
Clinical approaches for integrating machine learning for patients with lymphoma: Current strategies and future perspectives Dai Chihara, Loretta J. Nastoupil, Christopher R. Flowers British Journal of Haematology.2023; 202(2): 219. CrossRef
Current Trend of Artificial Intelligence Patents in Digital Pathology: A Systematic Evaluation of the Patent Landscape Muhammad Joan Ailia, Nishant Thakur, Jamshid Abdul-Ghafar, Chan Kwon Jung, Kwangil Yim, Yosep Chong Cancers.2022; 14(10): 2400. CrossRef
Recent Application of Artificial Intelligence in Non-Gynecological Cancer Cytopathology: A Systematic Review Nishant Thakur, Mohammad Rizwan Alam, Jamshid Abdul-Ghafar, Yosep Chong Cancers.2022; 14(14): 3529. CrossRef
Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation Yosep Chong, Nishant Thakur, Ji Young Lee, Gyoyeon Hwang, Myungjin Choi, Yejin Kim, Hwanjo Yu, Mee Yon Cho Diagnostic Pathology.2021;[Epub] CrossRef